These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
850 related articles for article (PubMed ID: 26291090)
1. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs. Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs. Masic A; Lu X; Li J; Mutwiri GK; Babiuk LA; Brown EG; Zhou Y Vaccine; 2010 Oct; 28(43):7098-108. PubMed ID: 20708697 [TBL] [Abstract][Full Text] [Related]
3. Vaccination of pigs with a codon-pair bias de-optimized live attenuated influenza vaccine protects from homologous challenge. Kaplan BS; Souza CK; Gauger PC; Stauft CB; Robert Coleman J; Mueller S; Vincent AL Vaccine; 2018 Feb; 36(8):1101-1107. PubMed ID: 29366707 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses. Abente EJ; Rajao DS; Santos J; Kaplan BS; Nicholson TL; Brockmeier SL; Gauger PC; Perez DR; Vincent AL J Virol; 2018 Nov; 92(22):. PubMed ID: 30185589 [TBL] [Abstract][Full Text] [Related]
5. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300 [TBL] [Abstract][Full Text] [Related]
7. Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease. Gauger PC; Loving CL; Khurana S; Lorusso A; Perez DR; Kehrli ME; Roth JA; Golding H; Vincent AL Virology; 2014 Dec; 471-473():93-104. PubMed ID: 25461535 [TBL] [Abstract][Full Text] [Related]
8. Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type. Sandbulte MR; Gauger PC; Kitikoon P; Chen H; Perez DR; Roth JA; Vincent AL Vaccine; 2016 Jul; 34(33):3773-9. PubMed ID: 27325350 [TBL] [Abstract][Full Text] [Related]
9. Divergent immune responses and disease outcomes in piglets immunized with inactivated and attenuated H3N2 swine influenza vaccines in the presence of maternally-derived antibodies. Sandbulte MR; Platt R; Roth JA; Henningson JN; Gibson KA; Rajão DS; Loving CL; Vincent AL Virology; 2014 Sep; 464-465():45-54. PubMed ID: 25043588 [TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of intranasally administered bivalent live influenza vaccine and immunological mechanisms underlying the protection. Pyo HM; Zhou Y Vaccine; 2014 Jun; 32(30):3835-42. PubMed ID: 24837774 [TBL] [Abstract][Full Text] [Related]
11. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs. Reeth KV; Brown I; Essen S; Pensaert M Virus Res; 2004 Jul; 103(1-2):115-24. PubMed ID: 15163499 [TBL] [Abstract][Full Text] [Related]
12. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model. Rudenko L; Kiseleva I; Krutikova E; Stepanova E; Rekstin A; Donina S; Pisareva M; Grigorieva E; Kryshen K; Muzhikyan A; Makarova M; Sparrow EG; Torelli G; Kieny MP PLoS One; 2018; 13(12):e0208028. PubMed ID: 30507951 [TBL] [Abstract][Full Text] [Related]
13. Localized mucosal response to intranasal live attenuated influenza vaccine in adults. Barría MI; Garrido JL; Stein C; Scher E; Ge Y; Engel SM; Kraus TA; Banach D; Moran TM J Infect Dis; 2013 Jan; 207(1):115-24. PubMed ID: 23087433 [TBL] [Abstract][Full Text] [Related]
14. Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets. Cherukuri A; Servat E; Woo J Vaccine; 2012 Jan; 30(2):237-46. PubMed ID: 22080173 [TBL] [Abstract][Full Text] [Related]
15. Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs. Souza CK; Rajão DS; Loving CL; Gauger PC; Pérez DR; Vincent AL Clin Vaccine Immunol; 2016 Jun; 23(6):470-482. PubMed ID: 27030585 [TBL] [Abstract][Full Text] [Related]
16. Swine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011-2012 H3N2v. Kitikoon P; Gauger PC; Anderson TK; Culhane MR; Swenson S; Loving CL; Perez DR; Vincent AL Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):32-41. PubMed ID: 24224818 [TBL] [Abstract][Full Text] [Related]
17. Influence of maternally-derived antibodies on live attenuated influenza vaccine efficacy in pigs. Pyo HM; Hlasny M; Zhou Y Vaccine; 2015 Jul; 33(31):3667-72. PubMed ID: 26092308 [TBL] [Abstract][Full Text] [Related]
18. Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs. Li C; Culhane MR; Cheeran M; Galina Pantoja L; Jansen ML; Amodie D; Mellencamp MA; Torremorell M Vet Res; 2020 Jul; 51(1):89. PubMed ID: 32646490 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vincent AL; Ma W; Lager KM; Janke BH; Webby RJ; García-Sastre A; Richt JA Vaccine; 2007 Nov; 25(47):7999-8009. PubMed ID: 17933442 [TBL] [Abstract][Full Text] [Related]
20. Serological profiles after consecutive experimental infections of pigs with European H1N1, H3N2, and H1N2 swine influenza viruses. Van Reeth K; Labarque G; Pensaert M Viral Immunol; 2006; 19(3):373-82. PubMed ID: 16987057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]